XWELL (NASDAQ:XWEL) Stock Price Up 0.6% – Here’s What Happened

XWELL, Inc. (NASDAQ:XWELGet Free Report) shares traded up 0.6% during mid-day trading on Friday . The company traded as high as $0.9756 and last traded at $0.9756. 16,438 shares changed hands during mid-day trading, a decline of 58% from the average daily volume of 39,345 shares. The stock had previously closed at $0.97.

Analysts Set New Price Targets

A number of analysts have commented on XWEL shares. Weiss Ratings upgraded shares of XWELL from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, August 24th. Wall Street Zen cut shares of XWELL from a “hold” rating to a “sell” rating in a report on Sunday, May 17th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, XWELL currently has a consensus rating of “Sell”.

Read Our Latest Research Report on XWEL

XWELL Trading Up 0.6%

The firm has a market capitalization of $8.23 million, a P/E ratio of -0.18 and a beta of 1.00. The business’s fifty day moving average is $1.01 and its 200 day moving average is $1.15.

XWELL (NASDAQ:XWELGet Free Report) last issued its earnings results on Friday, August 14th. The company reported ($0.26) earnings per share for the quarter, topping analysts’ consensus estimates of ($1.00) by $0.74. The firm had revenue of $7.14 million during the quarter, compared to analysts’ expectations of $2.37 million. XWELL had a negative net margin of 82.90% and a negative return on equity of 1,091.48%.

XWELL Company Profile

(Get Free Report)

XWELL, Inc provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.

See Also

Receive News & Ratings for XWELL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XWELL and related companies with MarketBeat.com's FREE daily email newsletter.